UroNurse Episode 183: Optimizing Care in Advanced Renal Cell Carcinoma: Immunotherapy & Targeted Agents Explained
Maximum Credits:
1.00 / AMA PRA Category 1 CreditTM
1.00 / ANCC Contact Hour
1.00 / CE for Pharmacists

Join Vic Senese, RN, BSN, FAUNA, as he hosts an in-depth discussion with renowned oncologist Eric Jonasch, MD, on optimizing the care of patients with advanced renal cell carcinoma (RCC). This session explores the latest advancements in immunotherapy and targeted agents, providing practical strategies for clinicians to maximize treatment effectiveness and improve patient outcomes.

Topics covered include:

How to select and sequence immunotherapy and targeted therapies in advanced RCC
Managing side effects while maintaining quality of life
Emerging research and clinical trial insights
Real-world strategies for personalizing treatment plans

This educational program offers 1.00 ANCC Contact Hour and is essential viewing for nurses, advanced practice providers, and healthcare professionals involved in oncology care.

Subscribe to my channel for more updates: https://www.youtube.com/@UroNurse1

The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

(Audio) Optimizing Care in Advanced Renal Cell Carcinoma: Immunotherapy & Targeted Agents Explained

UroNurse